Home / 2020 / September (Page 6)

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-dose Syringe, a therapeutic equivalent generic version of Faslodex® (fulvestrant) Injection, 250 mg/5

READ MORE
Newsletter Popup
MedgateToday

Every major healthcare update,
delivered to your inbox

Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.

🔒 No spam. Unsubscribe anytime.